Your browser doesn't support javascript.
loading
Epithelium-off photochemical corneal collagen cross-linkage using riboflavin and ultraviolet a for keratoconus and keratectasia: a systematic review and meta-analysis.
Craig, Joyce A; Mahon, James; Yellowlees, Ann; Barata, Teresa; Glanville, Julie; Arber, Mick; Mandava, Lakshmi; Powell, John; Figueiredo, Francisco.
Affiliation
  • Craig JA; York Health Economics Consortium, University of York, UK. Electronic address: joyce.craig@york.ac.uk.
  • Mahon J; York Health Economics Consortium, University of York, UK.
  • Yellowlees A; Quantics Consulting Ltd, Edinburgh, UK.
  • Barata T; Quantics Consulting Ltd, Edinburgh, UK.
  • Glanville J; York Health Economics Consortium, University of York, UK.
  • Arber M; York Health Economics Consortium, University of York, UK.
  • Mandava L; National Institute for Health and Care Excellence, Manchester, UK.
  • Powell J; National Institute for Health and Care Excellence, Manchester, UK.
  • Figueiredo F; Royal Victoria Infirmary, Newcastle University, Newcastle upon Tyne, UK.
Ocul Surf ; 12(3): 202-14, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24999102
ABSTRACT
This report presents the results of a systematic review and meta-analyses of studies on epithelium-off photochemical corneal collagen cross-linkage for the management of keratoconus and secondary ectasia. The literature search identified 3,400 records of which 49 were considered for inclusion in the meta-analyses. Eight papers reported 4 unique randomized controlled trials, 29 studies were prospective, and 12 were retrospective studies. The majority of the studies (39/49) were graded as very low quality evidence. Twenty-six studies described adverse events and were included in the safety analysis. Meta-analyses are presented for changes in four

outcomes:

visual acuity, topography, refraction and astigmatism, and central corneal thickness. Statistically significant improvements were found in all efficacy outcomes at 12 months after the operation. Common side effects were pain, corneal edema, and corneal haze, which resolved usually within a few days after the procedure. The remaining uncertainty is duration of benefit to establish the procedure's potential benefit in avoiding or delaying disease progression and possibly reducing the need for corneal transplantation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Riboflavin / Ultraviolet Therapy / Collagen / Corneal Stroma / Keratoconus Type of study: Clinical_trials / Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: Ocul Surf Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Riboflavin / Ultraviolet Therapy / Collagen / Corneal Stroma / Keratoconus Type of study: Clinical_trials / Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: Ocul Surf Year: 2014 Document type: Article